FDA
-
-
-
-
-
-
-
Beren Therapeutics Secures $300M Financing to Support the Potential Commercial Launch of Adrabetadex and Long-Term Care Initiatives for Infantile-Onset Niemann-Pick Disease, Type C
-
-
-
-
-
-
-
Compass Pathways Announces FDA Acceptance of IND Application for PTSD and Hosts Webinar on PTSD and TRD
-
-
-
-
-
-
-
Savara Enters Into Non-Dilutive Debt Financing for up to $200M With Hercules Capital
-
-
-
-
-
-
-
Phathom Pharmaceuticals Announces Expansion of Existing Loan and Security Agreement with Hercules Capital
-
-
-
-
-
-
-
Provention Bio Announces $125 Million Term Loan Facility with Hercules Capital
-
-
-
-
-
-
-
Tarsus Completes Enrollment for the Pivotal Phase 3 Saturn-2 Trial of TP-03 to Treat Demodex Blepharitis and Secures $175 Million Credit Facility
-
-
-
-
-
-
-
Better Therapeutics Secures $50 Million Debt Facility From Hercules Capital
-
334,271 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


